Take part in CCSN’s important survey on Xgeva!

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of denosumab (Xgeva) for the prevention of skeletal-related events due to bone metastases from solid tumours. The information gathered from this survey will be used in order to prepare a patient evidence submission to

Giving a Voice to Men with Metastatic Prostate Cancer: Awareness Reception at Queen’s Park on September 27, 2012

TORONTO, September 20, 2012 – In recent years, prostate cancer awareness and research has made significant headway with global educational campaigns focused on prevention and survivorship; however, less attention has been given to prostate cancer in the advanced stages – for men whose cancer has spread, or metastasized – and who are running out of time. September is